The former commissioner of the US Food and Drug Administration, Scott Gottlieb, tells Reuters that in his new role as a venture capitalist, he is interested in supporting companies examining new antibiotics.
“I’m very interested in finding opportunities in the anti-infective space, particularly around multi-drug resistant organisms,” Gottlieb tells Reuters. “Anti-infectives have been unloved for a very long time. There’s a huge clinical need.”
{iframe}https://www.genomeweb.com/scan/gottliebs-vc-focus{/iframe}